Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) PT at $70.83
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) has earned a consensus recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have updated their coverage on the stock […]
More Stories
Metals Acquisition (NYSE:MTAL) Receives Sector Perform Rating from Scotiabank
Scotiabank restated their sector perform rating on shares of Metals Acquisition (NYSE:MTAL – Free Report) in a report issued on...
Lowe’s Companies (NYSE:LOW) Price Target Cut to $240.00 by Analysts at Stifel Nicolaus
Lowe’s Companies (NYSE:LOW – Free Report) had its price objective lowered by Stifel Nicolaus from $250.00 to $240.00 in a...
REV Group (NYSE:REVG) Price Target Raised to $30.00
REV Group (NYSE:REVG – Free Report) had its price target raised by The Goldman Sachs Group from $26.00 to $30.00...
Greif (GEF) Expected to Announce Earnings on Wednesday
Greif (NYSE:GEF – Get Free Report) is projected to release its Q2 2025 earnings data after the market closes on...
Ambarella (NASDAQ:AMBA) Price Target Cut to $80.00 by Analysts at Morgan Stanley
Ambarella (NASDAQ:AMBA – Free Report) had its price target decreased by Morgan Stanley from $90.00 to $80.00 in a research...
Doximity (NASDAQ:DOCS) Price Target Lowered to $60.00 at JPMorgan Chase & Co.
Doximity (NASDAQ:DOCS – Free Report) had its target price trimmed by JPMorgan Chase & Co. from $63.00 to $60.00 in...